Carsten T Viehl
The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination
Ramser M, Warschkow R, Viehl C, Kettelhack C, Zettl A, Lobbes L, Zuber M, Weixler B. The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination. World J Surg 2021
Dec 27, 2021The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination
Dec 27, 2021World J Surg 2021
Ramser Michaela, Warschkow Rene, Viehl Carsten T, Kettelhack Christoph, Zettl Andreas, Lobbes Leonard A, Zuber Markus, Weixler Benjamin
Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study
Weixler B, Viehl C, Van de Velde C, Vahrmeijer A, Zettl A, Gueller U, Demartines N, Warschkow R, Teixeira da Cunha S, Zuber M. Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study. World J Surg 2021; 45:1526-1536.
Jan 29, 2021Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study
Jan 29, 2021World J Surg 2021; 45:1526-1536
Weixler Benjamin, Viehl Carsten T, Van de Velde Cornelis J H, Vahrmeijer Alexander, Zettl Andreas, Gueller Ulrich, Demartines Nicolas, Warschkow Rene, Teixeira da Cunha Sofia, Zuber Markus
Evaluation of the prognostic relevance of the recommended minimum number of lymph nodes in colorectal cancer-a propensity score analysis
Ramser M, Lobbes L, Warschkow R, Viehl C, Lauscher J, Droeser R, Kettelhack C, Zuber M, Weixler B. Evaluation of the prognostic relevance of the recommended minimum number of lymph nodes in colorectal cancer-a propensity score analysis. Int J Colorectal Dis 2021; 36:779-789.
Jan 16, 2021Evaluation of the prognostic relevance of the recommended minimum number of lymph nodes in colorectal cancer-a propensity score analysis
Jan 16, 2021Int J Colorectal Dis 2021; 36:779-789
Ramser Michaela, Lobbes Leonard A, Warschkow Rene, Viehl Carsten T, Lauscher Johannes C, Droeser Raoul A, Kettelhack Christoph, Zuber Markus, Weixler Benjamin
Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule
Rueff J, Weixler B, Viehl C, Ochsner A, Warschkow R, Gueller U, Mingrone W, Zuber M. Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule. J Surg Oncol 2020
May 14, 2020Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule
May 14, 2020J Surg Oncol 2020
Rueff Jessica, Weixler Benjamin, Viehl Carsten T, Ochsner Alex, Warschkow Rene, Gueller Ulrich, Mingrone Walter, Zuber Markus
Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
Jakob M, Gueller U, Ochsner A, Oertli D, Zuber M, Viehl C. Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes. BMC Surg 2018; 18:81.
Oct 3, 2018Lymph node ratio is inferior to pN-stage in predicting outcome in colon cancer patients with high numbers of analyzed lymph nodes
Oct 3, 2018BMC Surg 2018; 18:81
Jakob Manuel O, Gueller Ulrich, Ochsner Alex, Oertli Daniel, Zuber Markus, Viehl Carsten T
Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial
Weixler B, Rickenbacher A, Raptis D, Viehl C, Gueller U, Rueff J, Zettl A, Zuber M. Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial. World J Surg 2017; 41:2378-2386.
Sep 1, 2017Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial
Sep 1, 2017World J Surg 2017; 41:2378-2386
Weixler Benjamin, Rickenbacher Andreas, Raptis Dimitri Aristotle, Viehl Carsten T, Gueller Ulrich, Rueff Jessica, Zettl Andreas, Zuber Markus
Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study
Weixler B, Viehl C, Warschkow R, Gueller U, Ramser M, Sauter R, Zuber M. Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study. JAMA Surg 2017
Jun 7, 2017Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study
Jun 7, 2017JAMA Surg 2017
Weixler Benjamin, Viehl Carsten T, Warschkow Rene, Gueller Ulrich, Ramser Michaela, Sauter Rafael, Zuber Markus
Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
Viehl C, Oertli D, Sauter G, Terracciano L, Langer I, Banz V, Ramser M, Rosenthal R, Dell-Kuster S, Gueller U, Weixler B, Zuber M. Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival. Cancer Med 2017; 6:918-927.
Apr 12, 2017Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival
Apr 12, 2017Cancer Med 2017; 6:918-927
Viehl Carsten T, Oertli Daniel, Sauter Guido, Terracciano Luigi, Langer Igor, Banz Vanessa, Ramser Michaela, Rosenthal Rachel, Dell-Kuster Salome, Gueller Ulrich, Weixler Benjamin, Zuber Markus
Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients
Weixler B, Warschkow R, Zettl A, Riehle H, Gueller U, Viehl C, Zuber M. Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients. World J Surg 2015; 39:2583-9.
Oct 1, 2015Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients
Oct 1, 2015World J Surg 2015; 39:2583-9
Weixler Benjamin, Warschkow Rene, Zettl Andreas, Riehle Hans-Martin, Gueller Ulrich, Viehl Carsten T, Zuber Markus
Blue dye injection does not induce dissemination of epithelial cells during SLN procedure in colon cancer patients
Larusson H, von Holzen U, Viehl C, Rezaeian F, Riehle H, Oertli D, Gueller U, Zuber M. Blue dye injection does not induce dissemination of epithelial cells during SLN procedure in colon cancer patients. Int J Colorectal Dis 2014; 29:689-92.
Apr 25, 2014Blue dye injection does not induce dissemination of epithelial cells during SLN procedure in colon cancer patients
Apr 25, 2014Int J Colorectal Dis 2014; 29:689-92
Larusson Hannes J, von Holzen Urs, Viehl Carsten T, Rezaeian Farid, Riehle Hans-Martin, Oertli Daniel, Gueller Ulrich, Zuber Markus
Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer
Viehl C, Gueller U, Langer I, Laffer U, Oertli D, Zuber M. Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. World J Surg 2013; 37:873-7.
Apr 1, 2013Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer
Apr 1, 2013World J Surg 2013; 37:873-7
Viehl Carsten T, Gueller Ulrich, Langer Igor, Laffer Urban, Oertli Daniel, Zuber Markus
Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?
Gueller U, Zettl A, Worni M, Langer I, Cabalzar-Wondberg D, Viehl C, Demartines N, Zuber M. Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?. Cancer 2012; 118:6039-45.
Jun 8, 2012Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?
Jun 8, 2012Cancer 2012; 118:6039-45
Gueller Ulrich, Zettl Andreas, Worni Mathias, Langer Igor, Cabalzar-Wondberg Daniela, Viehl Carsten T, Demartines Nicolas, Zuber Markus
Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer
Viehl C, Oertli D, Laffer U, Riehle H, Terracciano L, Ochsner A, Langer I, Cecini R, Gueller U, Zuber M. Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol 2012; 19:1959-65.
Feb 10, 2012Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer
Feb 10, 2012Ann Surg Oncol 2012; 19:1959-65
Viehl Carsten T, Oertli Daniel, Laffer Urban, Riehle Hans-Martin, Terracciano Luigi, Ochsner Alex, Langer Igor, Cecini Ramona, Gueller Ulrich, Zuber Markus
Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients
Viehl C, Langer I, Gueller U, Zanetti-Dällenbach R, Moch H, Wight E, Oertli D, Zuber M. Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients. J Surg Oncol 2011; 103:531-3.
May 1, 2011Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients
May 1, 2011J Surg Oncol 2011; 103:531-3
Viehl Carsten T, Langer Igor, Gueller Ulrich, Zanetti-Dällenbach Rosanna, Moch Holger, Wight Edward, Oertli Daniel, Zuber Markus
Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Langer I, Gueller U, Viehl C, Moch H, Wight E, Harder F, Oertli D, Zuber M. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Indian J Surg Oncol 2010; 1:59-67.
Aug 7, 2010Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Aug 7, 2010Indian J Surg Oncol 2010; 1:59-67
Langer Igor, Gueller Ulrich, Viehl Carsten T, Moch Holger, Wight Edward, Harder Felix, Oertli Daniel, Zuber Markus
Inadequate quality of surveillance after curative surgery for colon cancer
Viehl C, Ochsner A, von Holzen U, Cecini R, Langer I, Gueller U, Laffer U, Oertli D, Zuber M. Inadequate quality of surveillance after curative surgery for colon cancer. Ann Surg Oncol 2010; 17:2663-9.
Apr 29, 2010Inadequate quality of surveillance after curative surgery for colon cancer
Apr 29, 2010Ann Surg Oncol 2010; 17:2663-9
Viehl Carsten T, Ochsner Alex, von Holzen Urs, Cecini Ramona, Langer Igor, Gueller Ulrich, Laffer Urban, Oertli Daniel, Zuber Markus
Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma
Adamina M, Spagnoli G, Marti W, Oertli D, Heberer M, Jacob A, Huegli R, Bolli M, Viehl C, Frey D, Weber W, Rosenthal R, Zajac P. Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma. Mol Ther 2010; 18:651-9.
Mar 1, 2010Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma
Mar 1, 2010Mol Ther 2010; 18:651-9
Adamina Michel, Spagnoli Giulio C, Marti Walter, Oertli Daniel, Heberer Michael, Jacob Augustinus L, Huegli Rolf W, Bolli Martin, Viehl Carsten T, Frey Daniel M, Weber Walter P, Rosenthal Rachel, Zajac Paul
Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Langer I, Gueller U, Viehl C, Moch H, Wight E, Harder F, Oertli D, Zuber M. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 2009; 16:3366-74.
Sep 4, 2009Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
Sep 4, 2009Ann Surg Oncol 2009; 16:3366-74
Langer Igor, Gueller Ulrich, Viehl Carsten T, Moch Holger, Wight Edward, Harder Felix, Oertli Daniel, Zuber Markus
[Follow-up recommendations for patients after curative treatment of invasive breast cancer]
Zuber M, Viehl C, Gueller U, Langer I. [Follow-up recommendations for patients after curative treatment of invasive breast cancer]. Ther Umsch 2008; 65:319-21.
Jun 1, 2008[Follow-up recommendations for patients after curative treatment of invasive breast cancer]
Jun 1, 2008Ther Umsch 2008; 65:319-21
Zuber Markus, Viehl Carsten T, Gueller Ulrich, Langer Igor
Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal
Rosenthal R, Viehl C, Gueller U, Weber W, Adamina M, Spagnoli G, Heberer M, Zuber M. Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal. J Am Coll Surg 2008; 207:95-105.
May 23, 2008Active specific immunotherapy phase III trials for malignant melanoma: systematic analysis and critical appraisal
May 23, 2008J Am Coll Surg 2008; 207:95-105
Rosenthal Rachel, Viehl Carsten T, Gueller Ulrich, Weber Walter P, Adamina Michel, Spagnoli Giulio C, Heberer Michael, Zuber Markus